SALT LAKE CITY (September 21, 2021)—Andrew Fletcher, MD, medical director of Consultative Services at ARUP Laboratories, and ARUP’s Consultative Services team, led by Sandy Richman, are among six healthcare leaders and systems honored with 2021 Choosing Wisely Champion Awards from the American Society for Clinical Pathology (ASCP). Launched in 2016, the Choosing Wisely Champions Program […]
This week Xenter, Backcountry, and Sera Prognostics announced changes to their executive teams. Here’s the deets: Xenter Salt Lake City, Utah-based Xenter, Inc. (XenterMD.com) has announced a new President of Xenter Medical Technologies (formerly Xenter Hospital Technologies) business unit. Mark Turco, MD, is highly qualified, coming from Sirtex Medical where he served as Executive Vice […]
Intermountain Healthcare and SCL Health, two leading nonprofit healthcare organizations, have signed a Letter of Intent to merge and create a model health system that provides high-quality, accessible, and affordable healthcare to more patients and communities in Utah, Idaho, Nevada, Colorado, Montana, and Kansas. Upon completion of the merger, the combined system will employ more […]
CMS Proposes MCIT Repeal On September 13, CMS issued a proposed rule to repeal the Medicare Coverage of Innovative Technology (MCIT) pathway initally finalized in a January 14, 2021 rule. The MCIT pathway would have provided four years of immediate Medicare coverage for FDA-designated breakthrough medical devices and diagnostics that have been market authorized – […]
Congressional committees this week got down to business writing the details of the Biden Administration’s $3.5 trillion “Build Back Better” reconciliation bill. Of particular interest to the life sciences industry was consideration of drug price control provisions in the House Energy and Commerce and Ways and Means Committees. In its version of “Build Back Better,” […]
Renalytix plc (NASDAQ: RNLX) (LSE: RENX) and the Mount Sinai Health System today announced scaled-up implementation of the KidneyIntelX™ early-stage risk assessment testing and care management program across primary care and specialty clinician networks under a real-world evidence development program for patients with diabetic kidney disease (DKD). KidneyIntelX enables a shift in focus from care […]
Clinical-stage medical device maker PhotoPharmics today announced a Clinical & Scientific Advisory board (CSAB) comprised of six leading experts in Parkinson’s disease (PD) and other neurodegenerative diseases. The board’s aim is to provide clinical and scientific advice and direction to support the PhotoPharmics mission to “Improve the lives of people who suffer from neurodegenerative diseases.” […]
The Saragene test kits approved by the CDSCO use the Company’s patented CoPrimer™ technology for the qualitative detection of these mosquito-borne viruses. According to the World Health Organization, the global incidence of dengue has grown dramatically in recent decades to become a leading cause of death in some Asian and Latin American countries, with 70% […]
AdvaMed, the leading global trade association for medical technology manufacturers, released the following statement from President and CEO Scott Whitaker on the Administration’s proposal to fully repeal the Medicare Coverage of Innovative Technologies (MCIT) rule.
On September 13th, Co-Diagnostics, Inc. announced that Company CEO Dwight Egan will participate in a panel discussion hosted by Scott Gottlieb, M.D., titled “How We Can Defeat the Next Pandemic” at the H.C. Wainwright & Co. 2021 Global Investor Conference, being held virtually on September 13-15, 2021.
Ultradent Products, Inc. is honored to be recognized a 2021 Fortune Magazine Best Workplace in Manufacturing and Production. The selection comes after a rigorous evaluation of company culture and extensive employee feedback.
The Utah Governor’s Office of Economic Opportunity has renamed its Salesforce grant application and customer service portals as part of its rebranding. The office no longer goes by GOED, but by Go Utah, or the Economic Opportunity office.
The Utah Governor’s Office of Economic Opportunity (Go Utah) and the Economic Development Corporation of Utah (EDCUtah) are pleased to announce that Cytiva will expand its facility in Logan, Utah, adding up to 396 new high-paying Utah jobs in the next 10 years. Capital expenditures associated with the project are $231 million.
Newly released data from the University of Utah’s Kem C. Gardner Policy Institute shows that Utah’s mature life sciences industry – our BioHive – continues to experience strong growth relative to state and national trends, even during the pandemic.
Last month, The Point of the Mountain released its latest Framework Plan.
Dan Lundergan, MHA, COO at University of Utah Health Hospitals and Clinics, has been appointed to the role of CEO. He has served as interim CEO since February and steps into the official role beginning immediately.
BlueWind Medical has announced that the 100th patient has been enrolled in its OASIS (Overactive bladder stimulation system) study—a clinical pivotal trial designed to test the safety and efficacy of the Renova iStim system in providing tibial neuromodulation (TNM) therapy.
Last month, BioUtah News and Events reported that the U.S. Ski and Snowboard Team would be using R-Zero’s hospital-grade, whole-room ultraviolet light disinfection system called Arc to mitigate against COVID-19 and other pathogens in their training rooms.
Peer-reviewed results describe the Company’s test being used to confirm the presence of the virus on community waste, including mutated strains
On Monday, U.S. Rep. Burgess Owens (R-UT-4) spent the day visiting a number of life sciences companies – Owlet, Spectrum Solutions, Merit Medical, Matia Robotics and ARUP Laboratories.
Ron Heffernan, Managing Partner at Mountain Pacific Partners recently announced the launch of Mountain Pacific’s newest funds.
World-renowned neurologist and movement disorders specialist joins PhotoPharmics as company advances breakthrough device through pivotal clinical trial and to commercialization.
Levangie brings extensive commercial operating experience to Renalytix, served on boards of Exact Sciences, Insulet Corporation and Hologic.
Salt Lake City-based specialty medical device distributor is poised for value-creating diversification and supply chain innovation.
With more than two decades of healthcare expertise, Hastings brings track record of leading transformative growth.
ARUP Laboratories recently announced an investment in Techcyte Inc. as part of the Orem, Utah-based company’s new $21 million funding round.
On Tuesday, the House Democrats passed a budget blueprint on a party line vote. That blueprint allows Committees in the House to start writing the administration’s $3.5 trillion social spending or “care infrastructure” legislation. Democrats hope to move the spending measure as a reconciliation measure in the Fall. Under the reconciliation process, only 51 votes […]
Nominations are now open for BioUtah’s 2021 awards. The deadline for nominations is September 18.
Known Medicine today announced the closure of its seed round of funding in the amount of $7.2 million led by Caffeinated Capital, with participation from Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and noted angel investors Chris Gibson, CEO & Co-Founder at Recursion Pharmaceuticals, Nish Bhat, previously Co-Founder at Color Genomics, and others.
Fluidx Medical’s GPX™ Embolic Device Use for Tumor Treatments Chosen for “BEST of GEST” Embolization Program at the Annual GEST Meeting.
ZIEN Medical Technologies, of Salt Lake City, Utah, announces the integration of Eclipse Design Innovations, of Woods Cross, Utah, as well as the Grand Opening of their new 16,000 sq foot manufacturing/R&D facility to continue to support the Utah Life Sciences industry.
Renalytix Plc announced the publication of results from an external chronic kidney disease budget impact analysis projecting 5-year savings of $1.1 billion dollars for a population of 100,000 patients with type 2 diabetes (T2DKD) and chronic kidney disease tested with the Renalytix KidneyIntelX™ testing solution. Savings were driven by more effective pharmacy management and appropriate specialist referral compared to current standard of care for patients at high risk for disease progression and kidney failure.
